Drew Armstrong

Author Archive

  •
    Aug 2, 2025
    Vinay Prasad Is Out at FDA
    FDA's CBER head Vinay Prasad exits agency after Sarepta gene therapy controversy and criticism over Covid vaccine decisions. Conservative media targeted his political views.
  •
    Jul 30, 2025
    Vinay Prasad Is Out at FDA
    FDA's CBER head Vinay Prasad exits agency after Sarepta gene therapy controversy and criticism over Covid vaccine decisions. Conservative media targeted his political views.
Copyright © RealClearHealth, LLC
© RealClearHealth | | Go to full site